Showing 8,181 - 8,200 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 1.05s Refine Results
  1. 8181

    Decreased levels of dCAP-D3/Condensin II result in a local loss of retrotransposon sequence <i>in vivo</i> and <i>in vitro</i>. by Andrew T. Schuster (478446)

    Published 2013
    “…<p>A) PCR performed on DNA from wild type (<i>w<sup>1118</sup></i>) adults and dCAP-D3 transheterozygous mutant adults (d<i>Cap-D3<sup>c07081</sup></i>d<i>Cap-D3<sup>/Δ25</sup></i>) to detect whether three different retrotransposon sequences (<i>mdg1-1403, G2-1077, X-978</i>) were present (P) or absent (A) in dCAP-D3 regulated gene clusters indicates absence of the retrotransposon sequence only in <i>dCap-D3</i> mutants. …”
  2. 8182
  3. 8183
  4. 8184

    Supplemental Materials for <i>The Effects of Massage Therapy in Decreasing Pain and Anxiety in Post-Surgical Patients with Breast Cancer: A Systematic Review and Meta-Analysis</i> by Jill Cole (15269089)

    Published 2024
    “…</p><p><b>Conclusion: </b>The current evidence in this study reflects that massage therapy is effective as a non-pharmacological tool in decreasing post-surgical pain and anxiety in women with breast cancer.…”
  5. 8185
  6. 8186
  7. 8187

    Image13_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  8. 8188
  9. 8189

    Image14_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  10. 8190
  11. 8191

    The m<sup>6</sup>A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells. by Jing Chen (4762)

    Published 2024
    “…<p>(A) The m<sup>6</sup>A peak marked in green is decreased in the 3’UTR of TLR4, TLR6, MYD88, TRIF, and other 7 genes from m<sup>6</sup>A-seq data in METTL14-knockdown PK-15 cells infected with CSFV (MOI = 1). …”
  12. 8192
  13. 8193

    The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mildly decreased spinal cord diameter without any other lesions at follow-up. by Hossein Pourmontaseri (19329565)

    Published 2025
    “…<p>The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mildly decreased spinal cord diameter without any other lesions at follow-up.…”
  14. 8194

    Image1_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
  15. 8195
  16. 8196

    The IL-17A response of expanded LPMCs to HP-pulsed APCs. by Victoria Serelli-Lee (156487)

    Published 2012
    “…LPMCs were co-cultured with autologous HP-pulsed APCs, either in the absence or presence of MHC Class II blocking antibody. The fold-decrease in response was calculated by dividing the supernatant concentration of IL-17A from the culture without MHC Class II blockade, by the IL-17A concentration in the culture with MHC Class II blockade. …”
  17. 8197

    The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study by Andrew S. Azman (121645)

    Published 2015
    “…<div><p>Background</p><p>In 2013, a stockpile of oral cholera vaccine (OCV) was created for use in outbreak response, but vaccine availability remains severely limited. …”
  18. 8198
  19. 8199

    Projected annual CH<sub>4</sub> (A) and N<sub>2</sub>O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a constant emission scenario. by Fabio Correddu (12501799)

    Published 2025
    “…<p>Projected annual CH<sub>4</sub> (A) and N<sub>2</sub>O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a constant emission scenario.…”
  20. 8200

    CPTA-glycine derivative, forming a hippurane-type spacer molecule, demonstrates a significantly decreased uptake in kidney at 1, 4 h p.i. and 4 h p.i. blocked with an excess of BN peptide. by Hanwen Zhang (307516)

    Published 2013
    “…<p>CPTA-glycine derivative, forming a hippurane-type spacer molecule, demonstrates a significantly decreased uptake in kidney at 1, 4 h p.i. and 4 h p.i. blocked with an excess of BN peptide.…”